Physician profile
Kai E Swenson
NPI 1114312485
$40,276.05
in general payments reported to CMS, 2019-2025
17 companies · $20K in 2025
The $20K reported for 2025 was more than what 95% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.99 · 2022: $490 · 2023: $597 · 2024: $19K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,000 · Consulting Fee: $5,150 · Education: $5,000 · Long Term Medical Supply Or Device Loan: $3,490 · Food and Beverage: $3,448 · Travel and Lodging: $1,097.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $12,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,000.00 |
| Consulting Fee | $5,150.00 |
| Education | $5,000.00 |
| Long Term Medical Supply Or Device Loan | $3,490.44 |
| Food and Beverage | $3,447.82 |
| Travel and Lodging | $1,097.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,545.22 | 2022-2025 | Da Vinci Surgical System |
| Boston Scientific Corporation | $12,910.87 | 2023-2025 | Ultraflex Esophageal Ng, General - Pulmonary, General - Therapies |
| Cook Incorporated | $4,550.00 | 2025 | |
| Fujifilm Sonosite, INC. | $3,490.44 | 2024 | |
| Pulmonx Corporation | $2,290.82 | 2022-2025 | Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Medical Device Business Services, INC. | $554.08 | 2024 | Monarch |
| Ethicon INC. | $374.11 | 2022-2025 | Monarch Platform |
| Erbe USA INC | $304.88 | 2022-2025 | Vio3/Apc3/Erbecryo2, Erbe Cryo2 |
| Pinnacle Biologics, INC | $224.56 | 2025 | Photofrin |
| Cook Medical LLC | $210.06 | 2025 | Wayne |
| Bard Peripheral Vascular, INC. | $171.13 | 2022 | |
| Steris Corporation | $157.66 | 2023 | |
| Olympus America INC. | $150.00 | 2024 | Single-Use Flexible Video Bronchoscope |
| Philips North America LLC | $126.93 | 2023 | |
| Genentech USA, INC. | $99.99 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galvanize Therapeutics, INC | $71.87 | 2025 | Aliya System |
| Medtronic, INC. | $43.43 | 2023 | Illumisite |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kai Swenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.